Susceptibility/Risk Biomarkers: Indicate increased risk of developing cancer. Eg. BRCA1/2 mutations for breast and ovarian cancer risk
Diagnostic Biomarkers: Used to confirm the presence of a disease. Eg. PSA for prostate cancer
Prognostic Biomarkers: Provide information about how a disease may develop or progress over the time (Recurrence or progression). Eg. Ki67 as a prognostic biomarker in breast cancer
Monitoring Biomarkers: Measured repeatedly to track the status of a disease or treatment over time.
Predictive Biomarkers: Help predict whether a patient will respond to a particular treatment.EG. HER2 protein expression on breast cancer can help to predict response to targeted therapies.
Pharmacodynamic/Response Biomarkers: Indicate a biological response to a treatment or intervention.
Safety Biomarkers: Signal potential harm or toxicity from a drug or exposure. Eg. ALT/AST rising as a sign of liver damage during treatment.